Thailand tightens grip on cannabis market with fresh regulatory clampdown

Thailand is accelerating efforts to rein in its cannabis sector through enhanced regulatory measures, marking a significant shift from the country's earlier permissive stance on the plant. The revised framework requires consumers to obtain prescriptions before purchasing cannabis products, a departure from the more relaxed regulations that had characterised the market in recent years.

Under the tightened rules, cannabis sales are now limited exclusively to licensed medical facilities, effectively eliminating over-the-counter availability and restricting access to supervised healthcare settings. The move reflects growing concerns among Thai authorities about the uncontrolled expansion of the cannabis industry and its societal implications.

The policy reversal underscores Thailand's changing approach to cannabis governance. While the country had previously moved toward decriminalisation, policymakers are now prioritising stricter oversight and medical gatekeeping as a means to prevent misuse and maintain public health standards.

These regulatory changes place Thailand among Southeast Asian nations reassessing their cannabis policies, balancing medical applications against broader public health considerations. The emphasis on prescription-based access and licensed facilities suggests authorities view medical legitimacy as a cornerstone of any permissible cannabis framework.